HUMABS
DEAD

Serial Number

87180081

Owner

Humabs BioMed SA

Attorney

Tamar Niv Bessinger

Filing Date

Sep 22, 2016

Add to watchlist:

No watchlists yet
View on USPTO

HUMABS Trademark

Serial Number: 87180081 • Registration: 5477354

HUMABS is a trademark filed by Humabs BioMed SA on September 22, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Humabs BioMed SA (2 trademarks)

Via Mirasole 1
Bellinzona CH-6500 , CH

Entity Type: 99

Trademark Details

Filing Date

September 22, 2016

Registration Date

May 22, 2018

Cancellation Date

December 6, 2024

Goods & Services

Pharmaceutical and veterinary products for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, viral, bacterial or protozoological infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; organic compounds, biomolecules or biological macromolecules in the nature of pharmaceutical preparations for pharmaceutical purposes, namely for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, viral, bacterial or protozoological infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; organic compounds, biomolecules or biological macromolecules in the nature of pharmaceutical preparations for the treatment of viral, bacterial or protozoological infections

Chemical products for industrial or scientific purposes, namely, chemical preparations for scientific purposes, chemical preparations for industrial purposes; reagents for laboratory purposes

Scientific and technology services, namely, scientific research, analysis and testing and research and design in the field of chemicals and biologicals; laboratory services, namely, laboratory services in the field of biological macromolecules, drug discovery, preclinical and clinical development of therapeutic products; research services, namely, scientific research, research in the field of biological macromolecules; research services in the field of employing biological macromolecules; research services in the field of optimizing biological macromolecules; services for testing pharmaceutical products in terms of their biological or drug behavior; services for carrying out pre-clinical or clinical studies, namely, conducting studies for preclinical and clinical testing of biological products; services for testing biological products

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 6, 2024 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 1, 2024 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Apr 1, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 1, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 1, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 1, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 1, 2024 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 22, 2023 REM1
REGISTERED-SUPPLEMENTAL REGISTER
May 22, 2018 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 17, 2018 PREV
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Apr 11, 2018 CNTA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 7, 2018 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 7, 2017 GNRN
NON-FINAL ACTION E-MAILED
Sep 7, 2017 GNRT
NON-FINAL ACTION WRITTEN
Sep 7, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2017 CRFA
ASSIGNED TO LIE
Aug 1, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 28, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 30, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 30, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 30, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 29, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2016 NWOS
NEW APPLICATION ENTERED
Sep 26, 2016 NWAP